Get started
Author

Wan Sun

The trans-omics landscape of COVID-19
2021 · Peng Wu, Dongsheng Chen, et al. · Nature Communications · 122
PDF
Palbociclib plus endocrine therapy in older women with HR+/HER2– advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies
2018 · Hope S. Rugo, Nicholas C. Turner, et al. · European Journal of Cancer · 91
Gut microbiota facilitate chronic spontaneous urticaria
2024 · Lei Zhu, Xingxing Jian, et al. · Nature Communications · 84
PDF
Impact of Acid‐Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH‐Dependent Solubility, With Different Food Intake Conditions
2017 · Wan Sun, Karen J. Klamerus, et al. · Clinical Pharmacology in Drug Development · 82
Identification of microRNAs in developing wheat grain that are potentially involved in regulating grain characteristics and the response to nitrogen levels
2020 · Gege Hou, Chenyang Du, et al. · BMC Plant Biology · 54
PDF
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach
2017 · Wan Sun, Peter J. O'Dwyer, et al. · The Journal of Clinical Pharmacology · 50
Development of a placebo effect model combined with a dropout model for bipolar disorder
2013 · Wan Sun, Thomas P. Laughren, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 15
Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women
2021 · Binghe Xu, Huiping Li, et al. · Cancer Chemotherapy and Pharmacology · 14
Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer.
2020 · Xueqing Wang, Jianming Chen, et al. · PubMed · 13
Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales
2020 · Wan Sun, Di Zhou, et al. · The Journal of Clinical Pharmacology · 12
P490 A vedolizumab population pharmacokinetic model including intravenous and subcutaneous formulations for patients with ulcerative colitis
2019 · M Rosario, D Polhamus, et al. · Journal of Crohn s and Colitis · 12
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease
2021 · Wan Sun, Blair Fennimore, et al. · Clinical Pharmacokinetics · 11
PDF
Abstract P4-22-03: Palbociclib in combination with endocrine therapy in treatment-naive and previously treated elderly women with HR+, HER2– advanced breast cancer: a pooled analysis from randomized phase 2 and 3 studies
2017 · HS Rugo, NC Turner, et al. · Cancer Research · 11
Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases
2020 · Wan Sun, Richard A. Lirio, et al. · Clinical Pharmacology in Drug Development · 9
PDF
Palbociclib exposure-response analyses in second-line treatment of hormone-receptor positive advanced breast cancer (ABC).
2017 · Wan Sun, Yanke Yu, et al. · Journal of Clinical Oncology · 9
P529 Exposure–response relationship of vedolizumab subcutaneous treatment in patients with ulcerative colitis: VISIBLE 1
2019 · M Rosario, D Polhamus, et al. · Journal of Crohn s and Colitis · 6
Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study
2017 · Huiping Li, Qingyuan Zhang, et al. · The Lancet Oncology · 5
SMQVP: A Web Application for Spatial Metabolomics Quality Visualization and Processing
2025 · Zhanlong Mei, Wan Sun, et al. · Metabolites · 4
PDF
Pharmacodynamic Modeling of CDK4/6 Inhibition‐Related Biomarkers and the Characterization of the Relationship Between Biomarker Response and Progression‐Free Survival in Patients With Advanced Breast Cancer
2021 · Yanke Yu, Wan Sun, et al. · The Journal of Clinical Pharmacology · 4
PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues – A population pharmacokinetic/pharmacodynamic analysis of rucaparib
2014 · Diane D. Wang, Chunze Li, et al. · Clinical Pharmacology in Drug Development · 4
Transcriptomic analysis of codon usage patterns and gene expression characteristics in leafy spurge
2024 · Zhanjun Wang, Jie Li, et al. · BMC Plant Biology · 3
S0876 Assessment of Vedolizumab Disease-Drug-Drug Interaction in Patients With Inflammatory Bowel Diseases
2020 · Wan Sun, Richard A. Lirio, et al. · The American Journal of Gastroenterology · 1
P509 Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease
2020 · W Sun, B Fennimore, et al. · Journal of Crohn s and Colitis · 1
PDF
Abstract CT048: Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2– advanced breast cancer (ABC) in Chinese women
2018 · Binghe Xu*, Qingyuan Zhang*, et al. · Cancer Research · 1
Lymphocyte-Predominant Ascites as a Clue to Peritoneal Tuberculosis: Two Case Reports and a Literature Review
2026 · Wan Sun, Keyuan Lai, et al. · Infection and Drug Resistance
PDF
Works count: 29
Citation count: 618
H-index: 11
I10-index: 13
Year
Topic
Type